Diagnosis of Small Cell Neuro-Endocrine Carcinoma Of Cervix

There are several differences between neuroendocrine and other types of cervical cancer, in prognosis, diagnosis and treatment. Neuroendocrine cancer of the uterine cervix is a rare and aggressive disease. Small cell carcinoma is classified as a neuroendocrine tumor in the currently used World Health Organization histological classification of tumors of the uterine cervix (2003). Small-cell carcinoma is one of the most aggressive, poorly differentiated, and highly malignant neuroendocrine tumors and includes small-cell lung cancer and extrapulmonary small cell carcinoma (EPSCC). EPSCC is a rare disease, accounting for 2 % of all small cell carcinoma. Because of the rare nature of this disease, clinical trials for neuroendocrine cancer of the cervix are lacking. Social media and other innovative techniques may be useful to identify patients with this rare tumor. Patients may benefit from receiving care from centers with expertise in treating this disease. Treatment for neuroendocrine cervical cancer is usually more intensive than that for most other types of cervical cancer and therapy often utilizes multiple different modalities such as surgery, chemotherapy and radiation.